欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

  1. Home
  2. 抗體
  3. 科研級生物類似抗體
  4. TPBG (PF-06263507 Biosimilar) Recombinant Monoclonal Antibody

TPBG (PF-06263507 Biosimilar) Recombinant Monoclonal Antibody

  • 貨號：
    CSB-RA024093MB2HU
  • 規格：
    ￥83486
  • 其他：

產品詳情

  • 產品描述：
    TPBG（PF-06263507 Biosimilar Antibody）重組單克隆抗體，其靶點為滋養層糖蛋白（TPBG），該蛋白也被稱為5T4癌胚抗原、5T4癌胚滋養層糖蛋白、5T4癌滋養層糖蛋白、M6P1、Wnt激活抑制因子1（WAIF1）等，在多種腫瘤中高表達，是重要的腫瘤相關抗原。本抗體以重組人TPBG蛋白制備，具有高度的種屬反應性，主要針對人類TPBG蛋白發揮特異性結合作用。 靶向TPBG類似物因5T4在胚胎發育過程中短暫表達，而在成人正常組織中低表達或不表達，但在肺癌、乳腺癌、結直腸癌、卵巢癌等多種惡性腫瘤中異常高表達，與腫瘤的侵襲、轉移及不良預后密切相關，作為腫瘤治療的潛在靶點備受關注。此類藥物通過特異性結合腫瘤細胞表面的5T4抗原，可能通過抗體依賴的細胞介導的細胞毒性作用（ADCC）、補體依賴的細胞毒性作用（CDC）等機制殺傷腫瘤細胞，或作為載體偶聯細胞毒素、放射性同位素等形成抗體偶聯藥物（ADC），實現對腫瘤的精準靶向治療。目前，相關臨床研究主要集中在評估其治療多種實體瘤的安全性、耐受性及抗腫瘤活性，探索其在聯合化療、免疫治療等方案中的協同效應，為晚期或轉移性腫瘤患者提供新的治療選擇。 在TPBG重組單克隆抗體是研究TPBG蛋白功能及腫瘤發生發展機制的重要工具。研究者可利用該抗體進行實驗，檢測細胞或組織中TPBG蛋白的表達水平、亞細胞定位及相互作用蛋白，深入探究其在腫瘤細胞增殖、凋亡、上皮-間質轉化（EMT）、血管生成等生物學過程中的作用機制。此外，通過構建TPBG高表達或敲除的細胞模型及動物模型，結合該抗體進行功能驗證，有助于揭示TPBG作為腫瘤標志物的潛在價值及作為治療靶點的可行性，為腫瘤的早期診斷和新型靶向藥物的研發提供實驗依據。同時，該抗體的種屬反應性為人類，確保了在人體細胞及組織樣本研究中的特異性和準確性，推動了從基礎研究到臨床轉化的相關探索。
  • Uniprot No.：
  • 基因名：
  • 別名：
    Trophoblast glycoprotein antibody; 5T4 oncofetal antigen antibody; 5T4 oncofetal trophoblast glycoprotein；5T4 oncotrophoblast glycoprotein antibody; M6P1 antibody; Wnt-activated inhibitory factor 1；WAIF1 antibody; TPBG antibody; 5T4
  • 反應種屬：
    Human
  • 免疫原：
    Recombinant Human TPBG protein
  • 免疫原種屬：
    Homo sapiens (Human)
  • 標記方式：
    Non-conjugated
  • 克隆類型：
    Monoclonal
  • 濃度：
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液：
    0.01M PBS，pH7.4
  • 產品提供形式：
    Liquid
  • 應用說明：
    Validation Status
    Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
    Guaranteed Quality
    ① Antibody purity?> 95% tested by SDS-PAGE.
    ② Endotoxin level < 0.1EU/ug tested by LAL method.
  • 儲存條件：
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期：
    In stock
  • 用途：
    It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.

產品評價

靶點詳情

  • 功能：
    May function as an inhibitor of Wnt/beta-catenin signaling by indirectly interacting with LRP6 and blocking Wnt3a-dependent LRP6 internalization.
  • 基因功能參考文獻：
    1. In extravillous trophoblasts, 5T4 may function in epithelial-to-mesenchymal transition during placentation. The role of syncytiotrophoblast 5T4 is unknown, but its abundance in shed syncytial vesicles may signify route of sensitization of the maternal immune system. PMID: 28481180
    2. Collectively, these findings demonstrate that an anti-5T4 antibody-drug conjugate reduces the fraction of cancer stem cells (CSC), and prevents local recurrence and suggest a novel therapeutic approach for patients with head and neck squamous cell carcinoma. PMID: 27780858
    3. We obtained GWS evidence (P < 2.7 x 10(-6)) for gene-based association in the total sample with a novel locus, TPBG (P = 1.8 x 10(-6)). PMID: 28183528
    4. In conclusion, the present study provided evidence that TPBG is involved in PDAC metastasis, and that TPBG and its associated signaling pathways may be a suitable target for pancreatic ductal adenocarcinoma therapy. PMID: 25738465
    5. 5T4 expression is mechanistically associated with the directional movement of cells through epithelial mesenchymal transition, facilitation of CXCL12/CXCR4 chemotaxis, blocking of canonical Wnt/beta-catenin while favouring non-canonical pathway signalling PMID: 25066861
    6. Tyrosine 325 plus the leucine-rich repeat 1 surface centered on a second exposed aromatic residue, phenylalanine 97, are essential for inhibition of Wnt/beta-catenin signaling. PMID: 24582434
    7. The surface expression of 5T4 marks the use of the CXCR4 rather than the CXCR7 receptor, with distinct consequences for CXCL12 exposure. PMID: 22956548
    8. 5T4 is a potential new antigen for targeted therapies such as immunotherapy in MPM, as it is overexpressed on mesothelioma cells and recognised by 5T4-specific cytotoxic T-cells. PMID: 22498111
    9. Glycosylation and epitope mapping of the 5T4 glycoprotein oncofoetal antigen PMID: 11903056
    10. Results sugest that 5T4 is a transient marker of human embryonic stem cell differentiation & that 5T4 phenotype, colony seeding density and culture conditions influence the maintenance of pluripotent hES cells and their differentiation to neural lineages. PMID: 16616918
    11. there is a repertoire of CD8 T cell recognition of 5T4 in normal human donors and some candidate HLA-A*0201 epitopes have been identified PMID: 16646078
    12. the mRNA expression of trophoblast glycoprotein is up-regulated in cells circulating within blood from women with preeclampsia. PMID: 17978129
    13. 5T4-based cancer vaccine: cytotoxic T lymphocyte epitopes identified in Trovax-vaccinated colorectal cancer patients PMID: 18567615
    14. colorectal cancer patients who had preexisting cell proliferative responses to 5T4 were longer-term survivors PMID: 18833005

    顯示更多

    收起更多

  • 亞細胞定位：
    Cell membrane; Single-pass type I membrane protein.
  • 組織特異性：
    Expressed by all types of trophoblasts as early as 9 weeks of development. Specific for trophoblastic cells except for amniotic epithelium. In adult tissues, the expression is limited to a few epithelial cell types but is found on a variety of carcinoma.
  • 數據庫鏈接：

    HGNC: 12004

    OMIM: 190920

    KEGG: hsa:7162

    STRING: 9606.ENSP00000358765

    UniGene: Hs.71947



×
生命科學計算平臺